Project |
---|
Scope |
---|
Define a set of best practices for data transparency and create a Good Transparency Practices guidance. The best practices will aim to ensure anonymised data is compliant with the legal requirements |
as defined by |
Regulators, as well as |
preserves as much data utility as possible. If possible, |
Regulators such as the European Medicines Agency (EMA) and Health Canada will be consulted to ensure that the guidance created by the |
working group reflects their current standards. The planned document will have a similar format |
as the Good Clinical Practices guidance created by the International Conference on Harmonisation (ICH). The Good Transparency Practices document will include: an introduction, a glossary of terms, a set of principles, and subsections dedicated to different parties involved in the anonymisation process (such as the trial sponsor and the entity performing the anonymisation) |
describing their responsibilities and providing guidance. Additional sections may be added as needed. |
Project
Problem Statement |
---|
Transparency initiatives allow public scrutiny and research in the application of new knowledge based on clinical data. Current GxP guidelines do not apply to transparency as it represents a different flow of data in which anonymisation is carried out on a copy of the regulated data. |
Project
Problem Impact |
---|
Good Transparency Practices (GTP) would provide a means to achieving accountability and traceability while providing reasonable assurance that privacy requirements are being upheld. |
Project Leads | |||
---|---|---|---|
Lauren Hepburn, ICON | lauren.hepburn@iconplclhepburn@privacy-analytics.com | ||
Abby McDonell, Privacy Analytics | Sarah Balay | shewitt@privacy||
Lauren White, PHUSE Senior Project Coordinator | Objectives & Deliverables | Timelines||
Define the full set of requirements for GTP | Q32021 | ||
Preparation of components of GTP | Q42021 |
| ||||||
---|---|---|---|---|---|---|
Project approved. | ||||||
Q1 2024 | ||||||
|
Objectives & Deliverables | Timelines |
---|---|
Good Transparency Practices guidance document | Q2 2023 |
Project Members | Organisations |
Abhinav Srivastva | Exelixis |
Benjamin C Shim | Eli Lilly |
Brenda Tiffin | Claritidox |
Devaki Thavarajah | Industry |
Manohara Basoor Halasiddappa | Algok Bio |
Mekhala Acharya | Takeda |
Sanjay Bagani | Xogene |
Sarah Balay | Privacy Analytics |
Sharon Niedecken | Pfizer |
Shannon Lefaivre | Roche |
Shweta Srivastava | Xogene | Sophia Zilber | Pfizer